Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications

27 Aug 2022

Abstract excerpt

Palmitoylethanolamide (PEA), the naturally occurring amide of ethanolamine and palmitic acid, is an endogenous lipid compound endowed with a plethora of pharmacological functions, including analgesic, neuroprotective, immune-modulating, and anti-inflammatory effects. Although the properties of PEA were first characterized nearly 65 years ago, the identity of the receptor mediating these actions has long remained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to Neurogenesis and neuroplasticity mechanisms
Share to Restless Legs Syndrome Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36139030
DOI: 10.3390/biom12091191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic ImplicationsPMID 36139030Read ↗

Therapeutic Use of Palmitoylethanolamide as an Anti-inflammatory and ImmunomodulatorSemantic proximity Read ↗

Chronic Oral Palmitoylethanolamide Administration Rescues Cognitive Deficit and Reduces Neuroinflammation, Oxidative Stress, and Glutamate Levels in A Transgenic Murine Model of Alzheimer’s DiseaseSemantic proximity Read ↗

The ApoC2 mimetic peptide D6PV enhances remyelination by stimulating oxidative phosphorylation in oligodendrocytesSemantic proximity Read ↗

Inhibition of lysophosphatidic acid receptor 1-3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stressSemantic proximity Read ↗

Sphingolipid Metabolism: A New Therapeutic Opportunity for Brain Degenerative DisordersSemantic proximity Read ↗

Rescue of hippocampal synaptic plasticity and memory performance by Fingolimod (FTY720) in APP/PS1 model of Alzheimer’s disease is accompanied by correction in metabolism of sphingolipids, polyamines, and phospholipid saturation compositionSemantic proximity Read ↗

Ceramide signalling in inherited and multifactorial brain metabolic diseasesSemantic proximity Read ↗

Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and Current Clinical TrialsSemantic proximity Read ↗

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of Parkinson’s diseaseSemantic proximity Read ↗

N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.Semantic proximity Read ↗

Omega 3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical TrialsSemantic proximity Read ↗

Mechanisms Driving Palmitate-Mediated Neuronal Dysregulation in the HypothalamusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.